Golden Drugs Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
- Paid Up Capital ₹ 3.59 Cr
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.00 Cr
- Satisfied Charges ₹ 24.50 Cr
About Golden Drugs
Golden Drugs Private Limited (GDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 August 2012 and has a history of 12 years and five months. Its registered office is in Bangalore, Karnataka.
The Corporate was formerly known as Golden Drug Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 3.59 Cr.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹24.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravindrakumar Kothari and Shailesh Siroya serve as directors at the Company.
Company Details
- LocationBangalore, Karnataka
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232KA2012PTC157474
- Company No.
039907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Golden Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindrakumar Kothari  | Director | 15-Nov-2018 | Current |
| Shailesh Siroya | Director | 12-Apr-2018 | Current |
Financial Performance of Golden Drugs.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Golden Drugs?
Unlock access to Golden Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kaunshya Investments Private LimitedShailesh Siroya is a mutual person
Lifezen Healthcare Private LimitedRavindrakumar Kothari and Shailesh Siroya are mutual person
- Bal Pharma Limited
Shailesh Siroya is a mutual person
Balance Clinics LlpRavindrakumar Kothari and Shailesh Siroya are mutual person
- Bal Research Foundation
Ravindrakumar Kothari and Shailesh Siroya are mutual person
- Aurum Research & Analytical Solutions Private Limited
Shailesh Siroya is a mutual person
Charges (Loans)
₹20.00 Cr
₹24.50 Cr
Charges Breakdown by Lending Institutions
- Others : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2024 | Others | ₹20.00 Cr | Open |
| 28 Sep 2018 | Tata Capital Financial Services Limited | ₹15.00 Cr | Satisfied |
| 15 Oct 2014 | Punjab National Bank | ₹5.50 Cr | Satisfied |
| 15 Oct 2014 | Punjab National Bank | ₹4.00 Cr | Satisfied |
How Many Employees Work at Golden Drugs?
Unlock and access historical data on people associated with Golden Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Golden Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
